Disease expertisestrengthens therapeuticdevelopment.
Independent disease-focused organizations contribute patient perspective, clinical context, scientific relationships, and other expertise that can improve understanding of therapeutic opportunities across autoimmune and immune-mediated diseases.
Connecting disease expertise across a shared therapeutic opportunity.
Disease insight, patient perspective and scientific relationships can inform therapeutic development across autoimmune and immune-mediated conditions.
Select a collaborator to learn about its focus.
National Multiple Sclerosis Society
A leading organization driving research and support for people affected by multiple sclerosis.
- National Multiple Sclerosis Society — Multiple sclerosis. A leading organization driving research and support for people affected by multiple sclerosis.
- Crohn's & Colitis Foundation — Crohn's disease & colitis (IBD). A leading nonprofit focused on research and care for inflammatory bowel disease.
- Scleroderma Research Foundation — Scleroderma. A leading funder of research to find better treatments and a cure for scleroderma.
- American Diabetes Association — Type 1 & autoimmune diabetes. The nation's leading voluntary health organization driving research, care, and advocacy across diabetes.
- Food Allergy Science Initiative — Food allergy. A research initiative advancing the fundamental science of food allergy toward new treatments.
- Complex Disorders Alliance (CODA) — Complex chronic & neuroimmune disorders. A nonprofit advancing collaborative neuroimmune research to develop better diagnostics and treatments for people with complex chronic disorders.Visit Complex Disorders Alliance (CODA) website
- Arthritis Foundation — Rheumatoid & inflammatory arthritis. The largest U.S. nonprofit dedicated to the prevention, control, and cure of arthritis.
- Beyond Celiac — Celiac disease. A leading patient-advocacy and research organization accelerating the path to a cure for celiac disease.
- Immune Boost Capital — Immunology & inflammation. A mission-driven capital partner advancing innovation across immune and inflammatory disease.
- National Psoriasis Foundation — Psoriasis & psoriatic disease. The leading nonprofit serving people living with psoriasis and psoriatic arthritis.
- Sjögren's Foundation — Sjögren's disease. The national organization advancing research, education, and care for Sjögren's disease.
How collaborators contribute
Collaborators can inform disease context, scientific diligence, translational planning and patient-centered development. Their roles remain independent; Vie makes investment decisions through its own governance.
The path from discovery to patients
Discovery
$1–10M
Investment / program
R&D activity
- Target ID. Identify therapeutic targets.
- Hit ID. Select or design a drug candidate and begin optimization.
Main participants
Academics · Not-for-profits · Industry
Development
$10–100M
Investment / program
R&D activity
- Pre-clinical. Assess safety and efficacy in regulatory-compliant models.
- Phase 1a. First-in-human evaluation of pharmacology and safety.
- Phase 1b/2a/2b. Establish dose and determine efficacy.
Main participants
Industry · VC-backed biotech · Big Pharma
Regulatory approval
$100M–1B
Investment / program
R&D activity
- Phase 3. Large-scale registrational studies for regulatory approval.
- Approval. Prepare and submit applications for drug approval.
Main participants
Big Pharma
Patients
Therapies delivered
Connect disease expertise with therapeutic opportunity.
Connect with Vie to explore how disease insight and patient perspective can inform therapeutic development.
Or email us directly at contact@vieventures.com.